#ShowMeYourPump Until No One Sees It
Almost instantly the hashtag #ShowMeYourPump was replicating all over the Internet, the diabetes community was retweeting, reblogging, liking and posting pictures of their own.
#ShowMeYourPump is everywhere! Instagram, Twitter, Facebook, Tumblr, diabetes blogs, news outlets - absolutely EVERYWHERE!
Less than two weeks ago Sierra Sandison was competing to be Ms. Idaho. When she walked out on stage in her black bikini, her insulin pump clipped to her waist, she had no idea that the image of her doing so was about to become a viral sensation. Later that evening, Sierra was Ms. Idaho, if you go back into her Twitter feed you can see the excitement, pictures and celebration that she was experiencing.
Photo from Sierra's Twitter feed. @sierra_anne93
Then she decided to post the picture of her in that black bikini, insulin pump at her side, on her social media platforms. Almost instantly the hashtag #ShowMeYourPump was replicating all over the Internet, the diabetes community was retweeting, reblogging, liking and posting pictures of their own. Later today I'll be speaking with Sierra for an Arden's Day interview that will also run on Huffington Post. In the meantime, get out your camera and show them your pump...
... Until No One Sees It!
JDRF appoints Derek Rapp as new President & CEO
From PR Newswire - http://www.prnewswire.com/news-releases/jdrf-appoints-derek-rapp-as-new-president--ceo-267933101.html
Derek Rapp
NEW YORK, July 21, 2014 /PRNewswire/ -- JDRF's International Board of Directors (IBOD) announced today the appointment of Derek Rapp, currently Vice Chair of the JDRF International Board of Directors, as its new President and CEO.
Rapp replaces Jeffrey Brewer who recently left his role as JDRF President and CEO since 2010. "Jeffrey Brewer has been a transformational CEO for JDRF," said John Brady, Chairman of the JDRF IBOD. "Because of his vision and leadership, we are on the verge of life-changing breakthroughs that will fundamentally improve the way people live with T1D. His relentless passion to drive our artificial pancreas program has truly earned him the moniker 'Father of the Artificial Pancreas.' And his steadfast commitment to realize promising beta cell encapsulation therapy has brought this therapy closer to reality. JDRF is a stronger, more efficient and more focused organization than it was four years ago. We are deeply grateful for the outstanding contributions he has made that have brought us closer than ever to creating a world without T1D."
"It is an honor to assume the role as JDRF's President and CEO," said Rapp. "JDRF is a unique organization with a powerful mission. I look forward to building on the strong foundation Jeffrey Brewer has created. I am excited to lead our incredibly talented team as we work together to deliver life-changing treatments, and eventually a cure, to those living with T1D today, on our way to preventing the disease for generations to come. In the end, I know that we will succeed because the passion, determination, and dedication of our donors and our army of volunteers across the world will accept nothing less."
Rapp has most recently been the Mergers and Acquisitions Lead for Monsanto Company and previously served 10 years as CEO of Divergence, Inc. a start-up biotechnology company. Rapp has been involved with JDRF since his son, Turner, was diagnosed with the disease in 2004. He has served on the JDRF IBOD since 2010. In addition to that role, he has served as Research Chair and as a member of the Research Committee, the Lay Review Committee, the Strategic Alliances Committee, the Development Committee, and the Advocacy Committee. His wife, Emily, recently completed a term as Board President for the Greater Missouri/Southern Illinois Chapter of JDRF.
"We are excited to have a volunteer such as Derek, who has the business acumen and management experience to lead our organization, as well as a track record of passionate and effective volunteer leadership, assume the helm of JDRF," said Brady. "Derek has been a successful CEO of a biotechnology start-up, and recently served as a senior executive of a complicated, global biotechnology business. He combines a strong understanding of what JDRF needs at this pivotal time with the kind of managerial intellect we believe will ensure a seamless transition."
JDRF President and CEO Jeff Brewer is Being Replaced
Read his Facebook statement
JDRF President and CEO Jeff Brewer announced Sunday night, via his FaceBook page, that the JDRF is going in a "different leadership direction".
Colour me disappointed...
Alcon Licenses Google Lens Technology
Looks like Novartis owned Alcon saw something promising in Google's lens technology.
Looks like Novartis owned Alcon saw something promising in Google's lens technology.
From New York Times: Joe Jimenez, the chief executive of Novartis, acknowledged in an interview that many previous attempts to develop noninvasive glucose tests had failed, noting that the company previously tried — and failed — to develop its own glucose-monitoring contact lenses several years ago.
What makes this case different is the involvement of Google’s engineers, he said. “One of the biggest hurdles was miniaturization, and that’s one of the biggest benefits that Google X brings,” he said. “This is a set of engineers that are really doing incredible things with technology.”
While the glucose-monitoring lens has gotten most of the attention, Mr. Jimenez said he was also encouraged by another lens in development that would work much like autofocus on a camera, by helping the eye focus on near objects, then readjusting when the user looks at something far away. He said that product was not as far along in development, and that both lenses were still early in their development.
Read the entire article here
Thyroid Disease & Type 1 Diabetes. Undiagnosed hypothyroidism in people with type 1 diabetes can quietly wreak havoc — slowing growth, dropping blood sugars, and draining energy.
💊 Levothyroxine tips
💡 When “normal labs” aren’t enough
🧬 Why type 1 and Hashimoto’s often come as a pair